Robert Sambursky
Fondatore presso Rapid Pathogen Screening, Inc.
Profilo
Robert P.
Sambursky is the founder of Rapid Pathogen Screening, Inc. (founded in 2004) and RPS Diagnostics, Inc. (founded in 2004).
He currently holds the position of President, Chief Executive Officer & Director at Lumos Diagnostics, Director at Visus Therapeutics, Inc., and President at Versa Holdings LLC (since 2022).
He previously served as Chief Medical Officer at Lumos Diagnostics Holdings Ltd.
in 2022.
Dr. Sambursky has an undergraduate degree from Brown University and graduate and doctorate degrees from Boston University School of Medicine.
Posizioni attive di Robert Sambursky
Società | Posizione | Inizio |
---|---|---|
Rapid Pathogen Screening, Inc.
Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Fondatore | 01/01/2004 |
RPS Diagnostics, Inc.
RPS Diagnostics, Inc. Medical SpecialtiesHealth Technology RPS Diagnostics, Inc. develops diagnostic solutions and medical instruments. Its product FebriDx is in-office test that uses a finger stick blood sample to help differentiate viral from bacterial acute respiratory infection. The company was founded by Robert P. Sambursky in 2004 and is headquartered in Sarasota, FL. | Fondatore | 01/01/2004 |
Lumos Diagnostics
Lumos Diagnostics Medical SpecialtiesHealth Technology Lumos Diagnostics develops and provides diagnostic solutions. It offers assay development, reader development, and point-of-care diagnostic solutions. The company is headquartered in Carlsbad, CA. | Amministratore Delegato | - |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Versa Holdings LLC
Versa Holdings LLC Financial ConglomeratesFinance Versa Holdings LLC provides investment services. The private company is based in Wilmington, DE. | Presidente | 05/08/2022 |
Precedenti posizioni note di Robert Sambursky
Società | Posizione | Fine |
---|---|---|
LUMOS DIAGNOSTICS HOLDINGS LIMITED | Amministratore Delegato | 11/04/2022 |
Formazione di Robert Sambursky
Brown University | Undergraduate Degree |
Boston University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LUMOS DIAGNOSTICS HOLDINGS LIMITED | Health Technology |
Aziende private | 5 |
---|---|
Rapid Pathogen Screening, Inc.
Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Health Services |
RPS Diagnostics, Inc.
RPS Diagnostics, Inc. Medical SpecialtiesHealth Technology RPS Diagnostics, Inc. develops diagnostic solutions and medical instruments. Its product FebriDx is in-office test that uses a finger stick blood sample to help differentiate viral from bacterial acute respiratory infection. The company was founded by Robert P. Sambursky in 2004 and is headquartered in Sarasota, FL. | Health Technology |
Versa Holdings LLC
Versa Holdings LLC Financial ConglomeratesFinance Versa Holdings LLC provides investment services. The private company is based in Wilmington, DE. | Finance |
Lumos Diagnostics
Lumos Diagnostics Medical SpecialtiesHealth Technology Lumos Diagnostics develops and provides diagnostic solutions. It offers assay development, reader development, and point-of-care diagnostic solutions. The company is headquartered in Carlsbad, CA. | Health Technology |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Robert Sambursky